Hydrazobenzene: Target Organs and Levels of Evidence for TR-092
Bioassay of Hydrazobenzene for Possible Carcinogenicity (CASRN 122-66-7)
Chemical (Study Title) CASRN | Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|
Hydrazobenzene 122-66-7 | 04/26/1978 | Dosed-Feed MR: 0,.008,.03 (AVG), FR: 0,.004,.01 (AVG), MM: 0,.008,.04 (AVG), FM: 0,.004,.04 (AVG) %/50 PER GROUP | T.S.I. Mason Laboratories, Inc. |
Levels of Evidence
Male Rats: Positive
Type | Organ/Tissue (Lesion) |
---|
Neoplastic Lesions | - Liver:
(CARCINOMA)
- Zymbal Gland:
(SQUAMOUS CELL PAPILLOMA OR CARCINOMA)
|
Female Rats: Positive
Type | Organ/Tissue (Lesion) |
---|
Neoplastic Lesions | - Liver:
(NEOPLASTIC NODULE)
- Mammary Gland:
(ADENOCARCINOMA)
|
Male Mice: Negative
Female Mice: Positive
Type | Organ/Tissue (Lesion) |
---|
Neoplastic Lesions | |